141 related articles for article (PubMed ID: 10485461)
1. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region.
Kanamori Y; Matsushima M; Minaguchi T; Kobayashi K; Sagae S; Kudo R; Terakawa N; Nakamura Y
Cancer Res; 1999 Sep; 59(17):4225-7. PubMed ID: 10485461
[TBL] [Abstract][Full Text] [Related]
2. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811
[TBL] [Abstract][Full Text] [Related]
4. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer.
Przybylowska K; Zielinska J; Zadrozny M; Krawczyk T; Kulig A; Wozniak P; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
J Exp Clin Cancer Res; 2004 Mar; 23(1):121-5. PubMed ID: 15149160
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
6. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
[TBL] [Abstract][Full Text] [Related]
7. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
[TBL] [Abstract][Full Text] [Related]
10. Interstitial collagenases as markers of tumor progression.
Brinckerhoff CE; Rutter JL; Benbow U
Clin Cancer Res; 2000 Dec; 6(12):4823-30. PubMed ID: 11156241
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.
Six L; Grimm C; Leodolter S; Tempfer C; Zeillinger R; Sliutz G; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2006 Mar; 100(3):506-10. PubMed ID: 16214204
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
14. The effect of a single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter on force-induced MMP-1 expression in human periodontal ligament cells.
Huang SF; Li YH; Ren YJ; Cao ZG; Long X
Eur J Oral Sci; 2008 Aug; 116(4):319-23. PubMed ID: 18705799
[TBL] [Abstract][Full Text] [Related]
15. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
16. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP
J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
19. Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women.
Ju W; Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jan; 217(2):191-6. PubMed ID: 15617836
[TBL] [Abstract][Full Text] [Related]
20. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
